Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp has demonstrated resilience in its Healthcare/Life Sciences segment, which generated $424 million in revenue for FQ4, reflecting a year-over-year increase of 2% and a quarter-over-quarter rise of 1%, with full-year revenues rising to $1.629 billion. Expectations for future growth remain strong, with the segment projected to achieve high-single-digit to low-double-digit growth in FQ1, driven by multiple program ramps and recovering customer demand. Furthermore, contributions from the Aerospace and Defense segment are anticipated to bolster overall revenue growth, aligning with the company's goal of 9-12% growth for FY26, supported by ongoing success in commercial air and defense initiatives.

Bears say

Plexus Corp's gross margin has declined to 9.9%, down from 10.1% in the previous quarter, indicating potential pressures on profitability. The company anticipates a decrease in Industrial revenues in the upcoming quarter due to seasonality and moderating demand, which, alongside a stagnation in Aerospace & Defense revenues, raises concerns about overall revenue stability. Additionally, company-specific risks—including manufacturing disruptions, demand shortfalls in key verticals, and competitive challenges—pose significant threats to Plexus's market position and operational effectiveness.

Plexus (PLXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 4 analysts, Plexus (PLXS) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $157.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $157.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.